User profiles for Jakob Jonnerby
Jakob JonnerbyResearch associate Verified email at imperial.ac.uk Cited by 548 |
Rapid increase in Omicron infections in England during December 2021: REACT-1 study
The unprecedented rise in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections during December 2021 was concurrent with rapid spread of the Omicron variant in …
infections during December 2021 was concurrent with rapid spread of the Omicron variant in …
[HTML][HTML] Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study
S Hakki, J Zhou, J Jonnerby… - The Lancet …, 2022 - thelancet.com
Background Knowledge of the window of SARS-CoV-2 infectiousness is crucial in
developing policies to curb transmission. Mathematical modelling based on scarce empirical …
developing policies to curb transmission. Mathematical modelling based on scarce empirical …
[HTML][HTML] Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England
The SARS-CoV-2 pandemic has been characterised by the regular emergence of genomic
variants. With natural and vaccine-induced population immunity at high levels, evolutionary …
variants. With natural and vaccine-induced population immunity at high levels, evolutionary …
[HTML][HTML] Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
Rapid transmission of the SARS-CoV-2 Omicron variant has led to record-breaking case
incidence rates around the world. Since May 2020, the REal-time Assessment of Community …
incidence rates around the world. Since May 2020, the REal-time Assessment of Community …
[HTML][HTML] SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY. 4.2
…, H Wang, B Bodinier, D Haw, J Jonnerby… - BMC infectious …, 2022 - Springer
Background Since the emergence of SARS-CoV-2, evolutionary pressure has driven large
increases in the transmissibility of the virus. However, with increasing levels of immunity …
increases in the transmissibility of the virus. However, with increasing levels of immunity …
[HTML][HTML] Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys
Background The Omicron wave of COVID-19 in England peaked in January 2022 resulting
from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and …
from the rapid transmission of the Omicron BA.1 variant. We investigate the spread and …
Hydrodynamic optical-field-ionized plasma channels
We present experiments and numerical simulations which demonstrate that fully ionized, low-density
plasma channels could be formed by hydrodynamic expansion of plasma columns …
plasma channels could be formed by hydrodynamic expansion of plasma columns …
Post-peak dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022
Background Rapid transmission of the SARS-CoV-2 Omicron variant has led to the highest
ever recorded case incidence levels in many countries around the world. Methods The REal-…
ever recorded case incidence levels in many countries around the world. Methods The REal-…
REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first …
…, H Wang, D Haw, M Whitaker, CE Walters, J Jonnerby… - medRxiv, 2021 - medrxiv.org
Background It has been nearly a year since the first vaccinations against SARS-CoV-2 were
delivered in England. The third wave of COVID-19 in England began in May 2021 as the …
delivered in England. The third wave of COVID-19 in England began in May 2021 as the …
[HTML][HTML] Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in …
Background Prevalence of SARS-CoV-2 infection with Delta variant was increasing in England
in late summer 2021 among children aged 5 to 17 years, and adults who had received …
in late summer 2021 among children aged 5 to 17 years, and adults who had received …